Department of Health Data Science, Yokohama City University Graduate School of Data Science, Yokohama, 236-8511, Japan.
Department of Anesthesiology, School of Medicine, Yokohama City University, Yokohama, Japan.
Can J Anaesth. 2023 May;70(5):901-914. doi: 10.1007/s12630-023-02442-1. Epub 2023 Mar 28.
Postoperative sleep disturbances are common. Although several studies have examined the effect of melatonin on postoperative sleep disturbances, the results have not reached any definitive conclusion. We sought to conduct a systematic review to compare the effects of melatonin and melatonin agonists on postoperative sleep quality with those of placebo or no treatment in adult patients who underwent surgery under general or regional anesthesia.
We searched MEDLINE, Cochrane Central Register of Controlled Trials, Embase, Web of Science, ClinicalTrials.gov, and the UMIN Clinical Trials Registry up to 18 April 2022. Randomized clinical trials examining the effects of melatonin or melatonin agonists in patients undergoing general or regional anesthesia with sedation for any surgery were eligible for inclusion. The primary outcome was sleep quality measured using a visual analog scale (VAS). The secondary outcomes were postoperative sleep duration, sleepiness, pain, opioid consumption, quality of recovery, and adverse events. A random-effects model was used to combine the results. We assessed study quality with the Cochrane Risk of Bias Tool version 2. We applied a trial sequential analysis to assess the precision of the combined results.
Eight studies (516 participants) were analyzed for sleep quality. Of those, four studies used only a short duration of melatonin, either on the night before and the day of surgery or only on the day of surgery. A random-effects meta-analysis showed that melatonin did not improve sleep quality measured by VAS compared with placebo (mean difference, -0.75 mm; 95% confidence interval, -4.86 to 3.35), with low heterogeneity (I, 5%). Trial sequential analysis revealed that the accrued information size (n = 516) reached the estimated required information size (n = 295). We downgraded the certainty of the evidence because of the high risk of bias. The effect on postoperative adverse events was comparable between the melatonin and control groups.
Our results indicate that melatonin supplementation does not improve postoperative sleep quality measured with the VAS compared with placebo in adult patients (GRADE: moderate).
PROSPERO (CRD42020180167); registered 27 October 2022.
术后睡眠障碍很常见。尽管已有多项研究探讨了褪黑素对术后睡眠障碍的影响,但结果尚未得出明确结论。我们旨在进行一项系统评价,比较褪黑素和褪黑素激动剂与安慰剂或不治疗在接受全身或区域麻醉下手术的成年患者中的术后睡眠质量的影响。
我们检索了 MEDLINE、Cochrane 对照试验中心注册库、Embase、Web of Science、ClinicalTrials.gov 和 UMIN 临床试验注册库,截至 2022 年 4 月 18 日。纳入了评估褪黑素或褪黑素激动剂在全身或区域麻醉下镇静下接受任何手术的患者中作用的随机临床试验。主要结局是使用视觉模拟量表(VAS)测量的睡眠质量。次要结局是术后睡眠时间、嗜睡、疼痛、阿片类药物消耗、恢复质量和不良事件。使用随机效应模型合并结果。我们使用 Cochrane 偏倚风险工具版本 2 评估研究质量。我们应用试验序贯分析来评估合并结果的精度。
有 8 项研究(516 名参与者)分析了睡眠质量。其中,4 项研究仅在手术前一晚和手术当天或仅在手术当天使用了短时间的褪黑素。随机效应荟萃分析显示,与安慰剂相比,褪黑素并未改善 VAS 测量的睡眠质量(平均差异,-0.75mm;95%置信区间,-4.86 至 3.35),异质性较低(I,5%)。试验序贯分析显示,累积信息量(n=516)达到了估计的所需信息量(n=295)。由于高偏倚风险,我们降低了证据的确定性。褪黑素组和对照组的术后不良事件效应相当。
我们的结果表明,与安慰剂相比,褪黑素补充并不能改善成年患者(GRADE:中度)术后 VAS 测量的睡眠质量。
PROSPERO(CRD42020180167);2022 年 10 月 27 日注册。